Data Provided by Refinitiv. Minimum 15 minutes delayed.
–
Summary ToggleIntellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
